| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INBX | Inhibrx, Inc. | Ott David C. | 10% Owner | Aug 28, 2023 | Buy | $19.35 | 511,627 | 9,899,983 | 511,627 | Aug 30, 2023, 08:44 PM | |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | Feb 28, 2023 | Sale | $25.02 | 60 | 1,501 | 2,486,192 | Mar 01, 2023, 04:41 PM | |
| INBX | Inhibrx, Inc. | Eckelman Living Trust Dated February 5, 2014 | 10% Owner | Feb 01, 2023 | Sale | $24.73 | 28,750 | 710,856 | 2,102,104 | Feb 02, 2023, 07:26 PM | |
| INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Feb 02, 2023 | Sale | $25.45 | 11,250 | 286,355 | 2,076,683 | Feb 02, 2023, 07:26 PM | |
| INBX | Inhibrx, Inc. | Lappe Family Trust | To be Verified | Jan 23, 2023 | Sale | $25.36 | 21,665 | 549,364 | 2,490,587 | Jan 24, 2023, 06:46 PM | |
| INBX | Inhibrx, Inc. | Lappe Family Trust | To be Verified | Jan 24, 2023 | Sale | $25.72 | 4,335 | 111,478 | 2,486,315 | Jan 24, 2023, 06:46 PM | |
| INBX | Inhibrx, Inc. | Kayyem Jon Faiz | Director | Jan 23, 2023 | Sale | $25.26 | 9,500 | 239,999 | 3,224,301 | Jan 23, 2023, 06:10 PM | |
| INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Jan 03, 2023 | Sale | $23.77 | 32,895 | 781,770 | 2,133,340 | Jan 04, 2023, 05:53 PM | |
| INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Jan 04, 2023 | Sale | $23.48 | 7,105 | 166,829 | 2,118,556 | Jan 04, 2023, 05:53 PM | |
| INBX | Inhibrx, Inc. | Kayyem Jon Faiz | Director | Dec 21, 2022 | Sale | $27.02 | 9,500 | 256,679 | 3,235,760 | Dec 22, 2022, 04:04 PM | |
| INBX | Inhibrx, Inc. | Lappe Family Trust | To be Verified | Dec 19, 2022 | Sale | $25.56 | 26,000 | 664,443 | 2,513,006 | Dec 20, 2022, 04:59 PM | |
| INBX | Inhibrx, Inc. | Eckelman Living Trust Dated February 5, 2014 | 10% Owner | Dec 06, 2022 | Sale | $27.22 | 40,000 | 1,088,683 | 2,174,626 | Dec 07, 2022, 04:30 PM | |
| INBX | Inhibrx, Inc. | Kayyem Jon Faiz | Director | Nov 21, 2022 | Sale | $29.89 | 9,500 | 283,972 | 3,250,068 | Nov 22, 2022, 04:42 PM | |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | Nov 17, 2022 | Sale | $27.88 | 26,000 | 724,910 | 2,557,293 | Nov 18, 2022, 05:06 PM | |
| INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | Nov 01, 2022 | Sale | $33.51 | 40,000 | 1,340,387 | 2,207,902 | Nov 02, 2022, 05:04 PM | |
| INBX | Inhibrx, Inc. | Kayyem Jon Faiz | Director | Oct 21, 2022 | Sale | $30.13 | 9,500 | 286,232 | 3,258,729 | Oct 24, 2022, 04:36 PM | |
| INBX | Inhibrx, Inc. | Lappe Family Trust | To be Verified | Oct 17, 2022 | Sale | $29.59 | 26,000 | 769,443 | 2,581,271 | Oct 18, 2022, 04:37 PM | |
| INBX | Inhibrx, Inc. | DRAGSA 50 LLC | 10% Owner | Oct 07, 2022 | Buy | $30.00 | 1,333,333 | 39,999,858 | 2,427,307 | Oct 12, 2022, 04:39 PM | |
| INBX | Inhibrx, Inc. | Eckelman Living Trust Dated February 5, 2014 | 10% Owner | Oct 04, 2022 | Sale | $27.82 | 40,000 | 1,112,813 | 2,274,105 | Oct 05, 2022, 04:15 PM | |
| INBX | Inhibrx, Inc. | Eckelman Living Trust Dated February 5, 2014 | 10% Owner | Sep 06, 2022 | Sale | $14.91 | 40,000 | 596,274 | 2,438,046 | Sep 07, 2022, 04:57 PM | |
| INBX | Inhibrx, Inc. | Eckelman Living Trust Dated February 5, 2014 | 10% Owner | Aug 02, 2022 | Sale | $17.70 | 24,500 | 433,625 | 2,491,053 | Aug 04, 2022, 04:33 PM | |
| INBX | Inhibrx, Inc. | Eckelman Living Trust Dated February 5, 2014 | 10% Owner | Aug 03, 2022 | Sale | $18.47 | 15,500 | 286,209 | 2,475,553 | Aug 04, 2022, 04:33 PM | |
| INBX | Inhibrx, Inc. | Eckelman Living Trust Dated February 5, 2014 | 10% Owner | Jul 07, 2022 | Sale | $17.17 | 40,000 | 686,800 | 2,515,553 | Jul 08, 2022, 04:03 PM | |
| INBX | Inhibrx, Inc. | Eckelman Living Trust Dated February 5, 2014 | 10% Owner | Apr 05, 2022 | Sale | $25.04 | 400 | 10,016 | 2,555,553 | Apr 07, 2022, 04:11 PM | |
| INBX | Inhibrx, Inc. | Eckelman Living Trust Dated February 5, 2014 | 10% Owner | Mar 24, 2021 | Sale | $19.02 | 17,000 | 323,340 | 2,555,953 | Mar 24, 2021, 07:12 PM | |
| INBX | Inhibrx, Inc. | Eckelman Living Trust Dated February 5, 2014 | 10% Owner | Feb 16, 2021 | Sale | $25.90 | 17,000 | 440,300 | 2,572,953 | Feb 18, 2021, 05:08 PM | |
| INBX | Inhibrx, Inc. | Wagner Klaus W. | Chief Medical Officer | Feb 16, 2021 | Sale | $24.32 | 156,474 | 3,805,448 | 234,709 | Feb 18, 2021, 05:06 PM | |
| INBX | Inhibrx, Inc. | Wagner Klaus W. | Chief Medical Officer | Feb 17, 2021 | Sale | $25.29 | 19,559 | 494,647 | 215,150 | Feb 18, 2021, 05:06 PM | |
| INBX | Inhibrx, Inc. | Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% Owner | Aug 26, 2020 | Buy | $18.92 | 180,219 | 3,409,865 | 1,427,307 | Aug 28, 2020, 04:29 PM | |
| INBX | Inhibrx, Inc. | Ott David C. | 10% Owner | Aug 24, 2020 | Buy | $19.43 | 46,161 | 897,001 | 1,161,784 | Aug 25, 2020, 07:47 PM | |
| INBX | Inhibrx, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Aug 25, 2020 | Buy | $19.36 | 85,304 | 1,651,687 | 1,247,088 | Aug 25, 2020, 07:47 PM |
Menu